[Photo caption: Kenneth McMahon, Managing Director Sales Solutions & Special
Services AMEA, accepting the award on behalf of FedEx Express. Photo source: FedEx]
Hong Kong SAR, China, November 18, 2021 — FedEx Express (FedEx), a subsidiary of FedEx Corp. (NYSE: FDX) and one of the world’s largest express transportation companies, has been named “Asia’s Best 3PLs for Vaccines” at the Asia Pacific Vaccine Excellence Awards 2021 (AVEA 2021).
FedEx was selected as “Asia’s Best 3PLs for Vaccines” by almost 1,700 voters, for its leading role in protecting shipment integrity and keeping vaccines moving across the globe. By using its robust networks, professional healthcare expertise and best-in-class cold chain and temperature monitoring technologies, FedEx has transported nearly 14,000 COVID-19 humanitarian aid shipments throughout the world since the start of the pandemic.
This includes:
- Approximately 110 kilotons of personal protective equipment and other healthcare supplies, including more than 2.5 billion masks worldwide since the start of the pandemic.
- More than 37 kilotons of personal protective equipment and other healthcare supplies inbound to the AMEA region during the first year and a half of the pandemic.
- To date, FedEx has delivered COVID-19 vaccines to more than 50 countries and territories worldwide, including the most recent shipments to communities in South Korea and Vietnam.
In its inaugural year, the Asia Pacific Vaccine Excellence Awards 2021 (AVEA 2021), organized by IMAPAC, celebrates the outstanding achievements of biopharmaceutical organizations, supply chain experts, and the newest technology solutions deployed in Asia for the development and distribution of vaccines.
“We are honored to receive this award. It is a true testament to the extraordinary efforts of our team members, who united behind the purpose of delivering mission-critical shipments safely and reliably to communities within our region,” said Kawal Preet, president, Asia Pacific, Middle East, and Africa Region, FedEx Express. “It was through a combination of our global network, advanced cold chain solutions, near real-time monitoring capabilities, and decades of experience in delivering temperature-sensitive vaccines, that we were able to provide an extra level of confidence to our customers in times of uncertainty. Our commitment is to continue to deliver more vaccines to communities where they’re needed most, helping businesses and communities rebuild their economies in the year ahead as they emerge from the pandemic.”
The Asia Pacific Vaccine Excellence Awards 2021 were held in conjunction with the 3rd Vaccine World Asia Congress 2021 and attracted over 800 representatives from Asia’s top vaccine and supply chain organizations. To learn more about AVEA 2021 awards, please visit https://imapac.com/2nd/en/business_conferences/asia-pacific-vaccine-awards-2/.
